17-7688679-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001143992.2(WRAP53):c.31C>T(p.Pro11Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0045 in 1,614,206 control chromosomes in the GnomAD database, including 235 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001143992.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WRAP53 | NM_001143992.2 | c.31C>T | p.Pro11Ser | missense_variant | 2/11 | ENST00000396463.7 | NP_001137464.1 | |
WRAP53 | NM_001143990.2 | c.31C>T | p.Pro11Ser | missense_variant | 2/11 | NP_001137462.1 | ||
WRAP53 | NM_001143991.2 | c.31C>T | p.Pro11Ser | missense_variant | 2/11 | NP_001137463.1 | ||
WRAP53 | NM_018081.2 | c.31C>T | p.Pro11Ser | missense_variant | 1/10 | NP_060551.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WRAP53 | ENST00000396463.7 | c.31C>T | p.Pro11Ser | missense_variant | 2/11 | 1 | NM_001143992.2 | ENSP00000379727.3 |
Frequencies
GnomAD3 genomes AF: 0.0231 AC: 3509AN: 152198Hom.: 129 Cov.: 32
GnomAD3 exomes AF: 0.00626 AC: 1573AN: 251400Hom.: 51 AF XY: 0.00456 AC XY: 620AN XY: 135898
GnomAD4 exome AF: 0.00257 AC: 3750AN: 1461890Hom.: 107 Cov.: 31 AF XY: 0.00222 AC XY: 1618AN XY: 727248
GnomAD4 genome AF: 0.0230 AC: 3509AN: 152316Hom.: 128 Cov.: 32 AF XY: 0.0218 AC XY: 1626AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Li-Fraumeni syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 04, 2017 | - - |
Dyskeratosis congenita, autosomal recessive 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Dyskeratosis Congenita, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Dyskeratosis congenita Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
WRAP53-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 01, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at